AlphaLiquid® HRR

AlphaLiquid® HRR is a tissue biopsy test designed for patients with advanced solid cancers. Our patented UniqSeq® technology detects tumor DNA for genomic analysis.

AlphaLiquid ® HRR detects the four classes of variations (SNV, INDEL, fusion, and CNV) in 15 HRR genes associated with PARP inhibitor. With this data, IMBDx can provide information on appropriate therapy options and related on-going clinical trials.

Recommended for：

• Patients who might need PARP inhibitor.

Gene List

Workflow

Ordering

Sample Collection

Transportation

Analysis Report

Icon reference: Arrow icons created by Creative Stall Premium - Flaticon